Startups

Isaac Health
New York, New York, United States
Isaac Health is the operating brand of 2GHealth Inc., a Delaware health-technology corporation formed in2021 (SEC CIK1924493). Its AI-enabled brain-health platform supports identifying cognitive concerns, coordinating specialist assessment and ongoing dementia care, and connecting patients and caregivers to virtual neurology, psychiatry, geriatric medicine, cognitive therapy and navigation services. The published co-founders are CEO Julius Bruch and chief medical officer Joel Salinas. The issuer’s legal terms explicitly distinguish the technology/administrative platform from separately operated medical groups, including Isaac Health Florida PA, Brain Health Medical PC and Isaac Health PC; the platform company does not own these medical groups, and clinical directory listings are qualified provider affiliations rather than automatic corporate employment. Its current published team contains administrative leaders, clinicians, advisers and care navigators. Clinical diagnoses and treatment decisions belong to the independent providers; marketing outcomes, AI screening patents and access to approved medicines do not prove FDA approval or independently established efficacy of this platform. The issuer announced completion of aUSD5.7M seed onJanuary29,2024 co-led by Meridian Street Capital and B Capital, with Primetime Partners, Co-Found Partners, VU Venture Partners and AirAngels. A separate SeriesA announcedAugust14,2025 was led by Flare Capital Partners with Industry Ventures, Black Opal Ventures and returning Meridian Street, B Capital and Primetime. The issuer announced rounded10.5M; its August19,2025 SEC notice reports the same fully sold equity offering at exactUSD10,443,495.82, with zero remaining. The first-sale date is not the final close date. A2024 SEC notice reports5,766,996 sold against a larger6,865,751 offering, qualified alongside the same5.7M seed rather than added as a second round. An earlier2022 filing reports1,265,000 sold of option/right securities toward1.3M, with35,000 remaining; instrument detail, named buyers, disbursement and final close remain undisclosed. Public cumulative funding16.3M and inconsistent rounded figures are not arithmetically converted into additional cash events.
Founded 2021







































































